DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ -- The global artificial intelligence (AI) in drug discovery market is projected to…
A new publication in a Nature Research journal describes the novel technology behind the recently FDA-cleared imaging modality, a major…
Visage innovates with Visage Chat, Visage 7 | AI and more SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Visage Imaging,…
Research Shows Potential to Improve Time on Treatment and Detection of High-Risk Toxicities for Blood Cancer Patients Using the Canopy…
Clinical data presented at SITC 2024 demonstrated COM701 (anti-PVRIG) mediated anti-tumor activity with durable responses and good tolerability profile in tumors…
Philips Spectral CT 7500 RT Spectral CT 7500 RT clinical November 12, 2024 Designed specifically for use in radiation oncology,…
Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data…
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…
November 12, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq Biodexa Pharmaceuticals PLC,…
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical…